Fortrea
Oren Cohen is an experienced medical professional with a robust background in clinical pharmacology and medical affairs. Currently serving as Chief Medical Officer and President of Clinical Pharmacology Services at Fortrea since May 2023, Oren Cohen previously held similar roles at Labcorp Drug Development from December 2017 to May 2023, overseeing clinical pharmacology operations globally. Prior experience includes serving as Chief Medical Officer at Viamet Pharmaceuticals and leadership positions at Quintiles, Inc. and the National Institute of Allergy and Infectious Diseases. Oren Cohen holds a Doctor of Medicine degree from Duke University School of Medicine and a Bachelor of Arts in Biochemistry from Brandeis University.
This person is not in the org chart
Fortrea
11 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.